Litchev Boyan Vesselinov
SEC CIK 1902726 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | Chief Medical Off | 150 | $2,520 | — | 1 | 2022-01-31 | 2022-01-31 |
Most active insiders at INDP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ben-Tzvi Avraham | Dir | — | — |
| 2 | Newman Michael James | CSO, Dir | — | — |
| 3 | Sassi Nir | CFO | — | — |
| 4 | Linscott Walt Addison | COO | — | — |
| 5 | Meckler Jeffrey A | Co-CEO, Dir, 10% | — | — |
Litchev Boyan Vesselinov made no open-market trades at INDP in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-19 | 2022-01-31+ | INDP | Indaptus Therapeutics, Inc. | Litchev Boyan Vesselinov | Chief Medical Off | P - Purchase | $2.19 | +1,150 | 150 | New | +$2,520 |
Purchase Sale Sale after option exercise All abbreviations